Catalog No.
RHK35001
Species reactivity
Human
Host species
Mouse
Isotype
IgG2a
Clonality
Monoclonal
Target
TRIM33, KIAA1113, RFG7, TIF1G, E3 ubiquitin-protein ligase TRIM33, Ectodermin homolog, RET-fused gene 7 protein, Protein Rfg7, RING-type E3 ubiquitin transferase TRIM33, Transcription intermediary factor 1-gamma, TIF1-gamma, Tripartite motif-containing protein 33
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
Q9UPN9
Applications
ELISA, IP
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
SAA1438
Anti-TIF1-beta autoantibody-positive dermatomyositis: a case-based review., PMID:40304756
[Cutaneous ulceration in dermatomyositis : Case reports with positive anti-NXP-2/anti-TIF1-gamma antibody status]., PMID:39820721
Innovation in Dermatomyositis., PMID:39542557
Anti-Sp4 and anti-CCAR1 autoantibodies in UK vs US patients with adult and juvenile-onset anti-TIF1γ-positive myositis., PMID:39514366
Increase in Mitochondrial Mass of Lymphocyte Subsets in Anti-MDA5 and TIF1-γ-Positive Dermatomyositis Patients., PMID:39291775
Clinical and laboratory features between anti-TIF1γ dermatomyositis with and without malignancy: 37 case series and a review., PMID:39258818
Coexistence of anti-KS and anti-TIF1-γ antibodies in clinically amyopathic dermatomyositis presenting with rapid progression of interstitial lung disease., PMID:39087260
Case report: Pneumatosis coli in an anti-TIF1-ɣ-positive dermatomyositis patient., PMID:38937988
A Rare Case of Anti-TIF-1γ Antibody Positive Dermatomyositis in Adulthood., PMID:38904327
Anti-TIF1-γ-associated dermatomyositis associated with recurrent metastatic triple-negative breast cancer: Dramatic clinical response to sacituzumab govitecan., PMID:38801008
Anti-TIF1-γ Antibody-Positive Dermatomyositis Leading to Identification of Diffuse Large B-Cell Lymphoma., PMID:38710865
Hallux patch during anti-transcription intermediary factor-1γ dermatomyositis., PMID:38641559
Erythrodermic dermatomyositis with anti-TIF1-γ antibodies., PMID:38615336
TIF1-gamma IgG2 isotype is not associated with malignancy in juvenile dermatomyositis patients., PMID:38498839
Assessing the sensitivity and specificity of myositis-specific and associated autoantibodies: a sub-study from the MyoCite cohort., PMID:38479813
Possible correlation between serum interleukin-8 levels and the activity of myositis in anti-NXP2 antibody-positive dermatomyositis., PMID:38174692
Anti-TIF-1γ Positive Juvenile Dermatomyositis Diagnosed with Atopic Dermatitis., PMID:37651063
Case Report: IgA Nephropathy in a Patient With Anti-Transcription Intermediary Factor-1γ Antibody-Positive Dermatomyositis., PMID:35185871
A Commercial Anti-TIF1γ ELISA Is Superior to Line and Dot Blot and Should Be Considered as Part of Routine Myositis-Specific Antibody Testing., PMID:35154119
Immune responses to CCAR1 and other dermatomyositis autoantigens are associated with attenuated cancer emergence., PMID:35040440
The Significance of Autoantibodies in Juvenile Dermatomyositis., PMID:34840975
Anti-TIF1 gamma-positive IPAF patient developed stage IVB lung squamous carcinoma in 1 year: a case report., PMID:34193090
Clinical characteristics of four myositis-specific autoantibodies with regulatory-approved testing in Japan: A Japanese multi-centre adult myositis patients' cohort., PMID:34088590
Cross-reactive anti-CENP-A autoantibodies induce analytic interference in anti-TIF1γ detection using line-dot immunoassay., PMID:34022038
Presence of anti-TIF-1γ, anti-Ro52, anti-SSA/Ro60 and anti-Su/Ago2 antibodies in breast cancer: a cross-sectional study., PMID:33876712
Autoantibody profiles in patients' sera associated with distribution patterns of dermatomyositis skin symptoms., PMID:33867178
Immune response to dermatomyositis-specific autoantigen, transcriptional intermediary factor 1γ can result in experimental myositis., PMID:33811031
Analysis of human total antibody repertoires in TIF1γ autoantibody positive dermatomyositis., PMID:33772100
Anti-TIF-1γ Antibody Detection Using a Commercial Kit vs In-House Immunoblot: Usefulness in Clinical Practice., PMID:33613568
A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies., PMID:33599244
Anti-TIF1γ antibody-positive dermatomyositis in a 15-year-old boy with Epstein-Barr virus-related nasopharyngeal cancer receiving nivolumab., PMID:33367923
[Dermatomyositis with squamous cell carcinoma of the lungs secondary to nivolumab treatment: a case report]., PMID:33115992
Myositis-specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies., PMID:32762037
Distinct tissue injury patterns in juvenile dermatomyositis auto-antibody subgroups., PMID:32758284
Amyopathic and anti-TIF1 gamma-positive dermatomyositis: analysis of a monocentric cohort and proposal to update diagnostic criteria., PMID:32666928
Transcriptional intermediary factor 1 (TIF1) and anti-TIF1γ antibody-positive dermatomyositis., PMID:32649853
A single-center, retrospective record review of malignancy prevalence in patients with dermatomyositis with anti-transcription intermediary factor 1γ antibodies via line immunoassay versus immunoprecipitation., PMID:32619611
Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis., PMID:32581161
Smad2/3-pathway ligand trap luspatercept enhances erythroid differentiation in murine β-thalassaemia by increasing GATA-1 availability., PMID:32351032
Ovoid palatal patch: a clue to anti-TIF1γ dermatomyositis., PMID:32332045
A Case of Dermatomyositis Along with Esophageal Cancer and Screening of Serum Transcriptional Intermediary Factor 1 Gamma Antibodies in Various Cancer Patients., PMID:32312948
Clinically amyopathic dermatomyositis with anti-transcriptional intermediary factor 1-γ autoantibody positivity., PMID:32259242
Clinical significance of serum levels of anti-transcriptional intermediary factor 1-γ antibody in patients with dermatomyositis., PMID:32103537
Integration of IgA and IgG Autoantigens Improves Performance of Biomarker Panels for Early Diagnosis of Lung Cancer., PMID:31924693
Anti-TIF1-γ autoantibodies: warning lights of a tumour autoantigen., PMID:31883334
[Dermatomyositis: new antibody, new classification]., PMID:31859626
Pregnancy triggers the onset of anti-transcriptional intermediary factor 1γ antibody-positive dermatomyositis: a case series., PMID:31665457
Anti-transcriptional intermediary factor 1-γ antibody as a biomarker in patients with dermatomyositis., PMID:31638280
A novel case of TIF1 gamma autoantibody positive dermatomyositis associated with a non-functional pancreatic neuroendocrine tumor., PMID:30982303
Trim33 is required for appropriate development of pre-cardiogenic mesoderm., PMID:30940539
For research use only. Not for human or drug use.
